The Global Health Body Raises Warning Over Critical Lack of Obesity Jabs
Less than one in 10 individuals who could benefit from GLP-1 drugs such as Wegovy can access them, warns the World Health Organization as it issues its first advice on the therapies.
Given in excess of 1,000,000,000 individuals worldwide currently obese, it is calling for more widespread and fairer availability to this class of drugs.
Per estimates, more than two billion are projected to be living with obesity by 2030 if no action is taken.
"The new guidelines affirms that excess weight is a long-term condition that can be treated with thorough and ongoing care," said the agency's head Tedros Adhanom Ghebreyesus.
Significant expense, constrained manufacturing, and logistical bottlenecks are significant obstacles to universal availability to the injections that can aid individuals in losing significant weight, says the agency.
Weight-Loss Drug Shortage
Even under the present most optimistic scenario, the manufacturing of such drugs might only reach around 100 million people – under 10% of the global need, as stated by the health organization.
The advice calls on nations and manufacturers to increase availability, via strategies such as voluntary licensing.
The intellectual property rights on the active ingredient – the primary component of the drug Wegovy – is set to lapse in multiple countries in 2026.
How Weight-Loss Injections Operate
GLP-1 drugs replicate a body's own hormone to reduce digestion speed, curb appetite and increase the sense of being full so users reduce food intake.
People usually see weight reduction in the initial weeks of commencing the regular doses.
Studies indicates users may put most of the weight back on a year later of discontinuing the treatment, because their normal food cravings resume.
Being above a healthy weight raises your likelihood for experiencing health problems, including type 2 diabetes, heart disease, brain attack, and some malignancies.
Obesity impacts individuals in all nations and was associated with millions of fatalities worldwide in 2024, as per the WHO.
